Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
568 GBX | -0.36% | -2.75% | -8.39% |
22/04 | Elixirr annual profit and revenue boosted by client wins | AN |
22/04 | Elixirr International plc Recommends Final Ordinary Share Dividend for Year 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 66% by 2025.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Ratings chart - Surperformance
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.39% | 332M | - | ||
+6.73% | 7.41B | A- | ||
-32.64% | 3.24B | - | ||
+6.59% | 2.66B | A- | ||
+11.38% | 1.75B | C+ | ||
-9.32% | 1.08B | - | - | |
+31.69% | 907M | - | ||
-7.64% | 714M | - | ||
-3.29% | 606M | C+ | ||
-8.30% | 539M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ELIX Stock
- Ratings Elixirr International plc